Prostate Specific Antigen (PSA) Test Global Market Report 2024

Global Prostate Specific Antigen PSA Test Market Report 2024

Prostate Specific Antigen (PSA) Test Global Market Report 2024 – By Type (Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types), By Application (Screening, Post-Treatment Monitoring, Other Applications), By End User (Hospitals, Diagnostic Centers, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Name: Prostate Specific Antigen (PSA) Test Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Prostate Specific Antigen (PSA) Test Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Prostate Specific Antigen (PSA) Test Global Market Report 2024

Proud Members Of

Prostate Specific Antigen (PSA) Test Market Definition

The prostate-specific antigen (PSA) test is a blood test that quantifies the presence of prostate-specific antigen in the body. This test is primarily used to screen for and monitor prostate cancer in men and measures the level of prostate-specific antigen in the blood.

The main types of prostate-specific antigen (PSA) tests are clinical laboratory improvement amendments (CLIA), enzyme-linked immunosorbent assay (ELISA), fluorescence immunoassay (FIA), and others. Clinical laboratory improvement amendments (CLIA) refer to a set of rules that govern laboratory testing and mandate that clinical laboratories obtain CMS certification before accepting human samples for diagnostic testing. These are used for several applications, including screening, post-treatment monitoring, and others, and by various end-users such as hospitals, diagnostic centers, research institutes, and others.

Prostate Specific Antigen (PSA) Test Market Segmentation

The prostate specific antigen (psa) test market covered in this report is segmented –

1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types

2) By Application: Screening, Post-Treatment Monitoring, Other Applications

3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users

Global Prostate Specific Antigen (PSA) Test Market Size 2023 to 2028: Graph

Prostate Specific Antigen (PSA) Test Market Size 2024 And Growth Rate

The prostate specific antigen (psa) test market size has grown rapidly in recent years. It will grow from $3.66 billion in 2023 to $4.13 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to increased awareness, aging population, medical advancements, clinical recommendations, pharmaceutical advancements.

Prostate Specific Antigen (PSA) Test Market Growth Forecast

The prostate specific antigen (psa) test market size is expected to see rapid growth in the next few years. It will grow to $6.4 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to advancements in test accuracy, personalized medicine approach, personalized medicine approach, global aging population. Major trends in the forecast period include shift towards biomarker combinations, technological innovations, point-of-care testing, digital health integration, focus on early detection and prevention.

Book your 30 minutes free consultation with our research experts

Prostate Specific Antigen (PSA) Test Market Driver: Increasing Prevalence Of Prostate Cancer Drives Growth In Prostate-Specific Antigen (PSA) Test Market

The increasing prevalence of prostate cancer is expected to propel the growth of the prostate-specific antigen (PSA) test market going forward. Prostate cancer is a condition in which cancer arises in the prostate gland, a component of the male and female reproductive systems. The prostate-specific antigen (PSA) test is commonly used as a screening tool for prostate cancer in men. It measures the level of PSA in the bloodstream, which will help with early detection and risk assessment. For instance, in March 2023, according to the reports shared by the American Society of Clinical Oncology (ASCO), a US-based professional oncology organization, in the US, an estimated 288,300 men were diagnosed with prostate cancer, and approximately 34,700 people died in 2023. Further, in 2020, globally, an estimated 1,414,259 people will be diagnosed with prostate cancer. Therefore, the rise in the prevalence of prostate cancer is driving the growth of the prostate-specific antigen (PSA) test market.

Prostate Specific Antigen (PSA) Test Market Driver: Rise In Chronic Diseases Fuels Growth Of Prostate-Specific Antigen (PSA) Test Market

The rise in chronic diseases is expected to support the growth of the prostate-specific antigen (PSA) test market going forward. Chronic diseases refer to long-term medical conditions that persist over an extended period and typically require ongoing medical attention and management. Prostate cancer is considered a chronic condition, as it often develops slowly and may require ongoing monitoring and management. The PSA test is a key tool for screening, diagnosing, and monitoring the progression of prostate cancer. For instance, in 2022, according to the National Library of Medicine, a US-based federal government organization and the world’s largest medical library, the number of people aged 50 and older who have at least one chronic illness is predicted to rise by 99.5%, to 142.66 million in 2050. Additionally, with 14.968 million people in 2050, the number of people with multimorbidity is expected to rise by 91.16%. Therefore, the rise in chronic diseases will drive the prostate-specific antigen (PSA) test market.

Global Prostate Specific Antigen (PSA) Test Market Major Players

Major companies operating in the prostate specific antigen (psa) test market report are Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc., AOBIOUS Inc., Boster Biological Technology Co. Ltd., Cell Biolabs Inc., Lomina AG

Global Prostate Specific Antigen (PSA) Test Market Trend: Technological Advancements Propel Innovation In The Prostate-Specific Antigen (PSA) Test Market

Technological advancements are the key trend gaining popularity in the prostate-specific antigen (PSA) test market. Major companies operating in the prostate-specific antigen (PSA) test market are developing advanced screening test tools to sustain their position in the market. For instance, in February 2023, LynxDx Inc., a US-based diagnostic company, launched MyProstateScore 2.0, a non-invasive urine prostate cancer screening test. This innovative test uses a combination of 18 biomarkers, including the novel gene fusion T2:ERG, to provide a personalized risk assessment for each patient. Additionally, this screening test offers highly accurate, stratified risk assessment insights to guide clinical decisions for patients with elevated prostate-specific antigen (PSA) or abnormal digital rectal exam (DRE) findings. Moreover, it has the potential to improve prostate cancer screening and treatment.

Global Prostate Specific Antigen (PSA) Test Market Trend: Innovations With Home Testing Kits For Prostate-Specific Antigen (PSA)

Major companies operating in the prostate-specific antigen (PSA) test market are focusing on product development and launches such as home testing kits for prostate-specific antigen (PSA) to sustain their position in the market. Home testing kits refer to self-administered diagnostic tools that allow individuals to collect samples, perform tests, and obtain results without the need for a visit to a healthcare facility. For instance, in September 2023, Randox, an Ireland-based health and toxicology company, unveiled an at-home testing kit for prostate-specific antigen (PSA). The PSA home test is designed to measure the levels of PSA in the blood, providing an indication of abnormalities within the prostate. PSA is a protein produced by prostate gland cells, and elevated levels can signal various conditions, including an enlarged prostate, prostatitis, or a urinary tract infection, in addition to the potential presence of prostate cancer.

Prostate Specific Antigen (PSA) Test Market Merger And Acquisition: Bayer AG Expands Prostate Cancer Portfolio With Acquisition Of Noria Therapeutics Inc. And PSMA Therapeutics Inc.

In June 2021, Bayer AG, a Germany-based pharmaceutical and biotechnology company, acquired Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. for an undisclosed amount. Through this acquisition, Bayer AG aims to expand its portfolio of targeted alpha therapies (TATs) for prostate cancer, access Noria's non-invasive urine test, and strengthen its position in the prostate cancer market. PSMA Therapeutics Inc. is a subsidiary of Noria Therapeutics Inc., a US-based manufacturer and developer of targeted therapeutic companies that provide prostate-specific antigen (PSA) test services for prostate cancer.

Regional Outlook For The Global Prostate Specific Antigen (PSA) Test Market

North America was the largest region in the prostate specific antigen (PSA) test market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (psa) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prostate specific antigen (psa) test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The prostate-specific antigen (PSA) test market includes revenues earned by entities by providing services such as prostate cancer detection, monitoring, PSA screening, prostatitis evaluation, complex PSA tests, and blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The prostate-specific antigen (PSA) test market research report is one of a series of new reports from The Business Research Company that provides prostate-specific antigen (PSA) test market statistics, including prostate-specific antigen (PSA) test industry global market size, regional shares, competitors with a prostate-specific antigen (PSA) test market share, detailed prostate-specific antigen (PSA) test market segments, market trends and opportunities, and any further data you may need to thrive in the prostate-specific antigen (PSA) test industry. This prostate-specific antigen (PSA) test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Prostate Specific Antigen (PSA) Test Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$4.13 billion
Revenue Forecast In 2033	$6.4 billion
Growth Rate	CAGR of 11.6% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types 2) By Application: Screening, Post-Treatment Monitoring, Other Applications 3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Siemens AG; F. Hoffmann-La Roche AG; Bayer AG; Abbott Laboratories; Becton Dickinson and Company; PerkinElmer Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Ortho-Clinical Diagnostics Inc.; DiaSorin SpA; OPKO Health Inc.; R&D Systems Inc.; Meso Scale Diagnostics LLC; Tosoh America Inc.; Fujirebio Europe N.V.; Boditech Med Inc.; DRG International Inc.; BioVision Inc.; Enzo Life Sciences Inc.; RayBiotech Inc.; Novus Biologicals LLC; Creative Diagnostics Inc.; Elabscience; LifeSpan BioSciences Inc.; American Laboratory Products Company Ltd.; Accuquik Inc.; AOBIOUS Inc.; Boster Biological Technology Co. Ltd.; Cell Biolabs Inc.; Lomina AG
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Prostate Specific Antigen (PSA) Test Market Characteristics

3. Prostate Specific Antigen (PSA) Test Market Trends And Strategies

4. Prostate Specific Antigen (PSA) Test Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Prostate Specific Antigen (PSA) Test Market Size and Growth

5.1. Global Prostate Specific Antigen (PSA) Test Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Prostate Specific Antigen (PSA) Test Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Prostate Specific Antigen (PSA) Test Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Prostate Specific Antigen (PSA) Test Market Segmentation

6.1. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Clinical Laboratory Improvement Amendments (CLIA)

Enzyme-Linked Immunosorbent Assay (ELISA)

Fluorescence Immunoassay (FIA)

Other Types

6.2. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Screening

Post-Treatment Monitoring

Other Applications

6.3. Global Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Diagnostic Centers

Research Institutes

Other End Users

7. Prostate Specific Antigen (PSA) Test Market Regional And Country Analysis

7.1. Global Prostate Specific Antigen (PSA) Test Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Prostate Specific Antigen (PSA) Test Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Prostate Specific Antigen (PSA) Test Market

8.1. Asia-Pacific Prostate Specific Antigen (PSA) Test Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Prostate Specific Antigen (PSA) Test Market

9.1. China Prostate Specific Antigen (PSA) Test Market Overview

9.2. China Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Prostate Specific Antigen (PSA) Test Market

10.1. India Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Prostate Specific Antigen (PSA) Test Market

11.1. Japan Prostate Specific Antigen (PSA) Test Market Overview

11.2. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Prostate Specific Antigen (PSA) Test Market

12.1. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Prostate Specific Antigen (PSA) Test Market

13.1. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Prostate Specific Antigen (PSA) Test Market

14.1. South Korea Prostate Specific Antigen (PSA) Test Market Overview

14.2. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Prostate Specific Antigen (PSA) Test Market

15.1. Western Europe Prostate Specific Antigen (PSA) Test Market Overview

15.2. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Prostate Specific Antigen (PSA) Test Market

16.1. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Prostate Specific Antigen (PSA) Test Market

17.1. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Prostate Specific Antigen (PSA) Test Market

18.5. France Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Prostate Specific Antigen (PSA) Test Market

19.9. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Prostate Specific Antigen (PSA) Test Market

20.13. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Prostate Specific Antigen (PSA) Test Market

21.1. Eastern Europe Prostate Specific Antigen (PSA) Test Market Overview

21.2. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Prostate Specific Antigen (PSA) Test Market

22.1. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Prostate Specific Antigen (PSA) Test Market

23.1. North America Prostate Specific Antigen (PSA) Test Market Overview

23.2. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Prostate Specific Antigen (PSA) Test Market

24.1. USA Prostate Specific Antigen (PSA) Test Market Overview

24.2. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Prostate Specific Antigen (PSA) Test Market

25.1. Canada Prostate Specific Antigen (PSA) Test Market Overview

25.2. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Prostate Specific Antigen (PSA) Test Market

26.1. South America Prostate Specific Antigen (PSA) Test Market Overview

26.2. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Prostate Specific Antigen (PSA) Test Market

27.1. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Prostate Specific Antigen (PSA) Test Market

28.1. Middle East Prostate Specific Antigen (PSA) Test Market Overview

28.2. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Prostate Specific Antigen (PSA) Test Market

29.1. Africa Prostate Specific Antigen (PSA) Test Market Overview

29.2. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Prostate Specific Antigen (PSA) Test Market Competitive Landscape And Company Profiles

30.1. Prostate Specific Antigen (PSA) Test Market Competitive Landscape

30.2. Prostate Specific Antigen (PSA) Test Market Company Profiles

30.2.1. Siemens AG

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. F. Hoffmann-La Roche AG

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Bayer AG

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Abbott Laboratories

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Becton Dickinson and Company

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Prostate Specific Antigen (PSA) Test Market Other Major And Innovative Companies

31.1. PerkinElmer Inc.

31.2. Beckman Coulter Inc.

31.3. Bio-Rad Laboratories Inc.

31.4. Ortho-Clinical Diagnostics Inc.

31.5. DiaSorin SpA

31.6. OPKO Health Inc.

31.7. R&D Systems Inc.

31.8. Meso Scale Diagnostics LLC

31.9. Tosoh America Inc.

31.10. Fujirebio Europe N.V.

31.11. Boditech Med Inc.

31.12. DRG International Inc.

31.13. BioVision Inc.

31.14. Enzo Life Sciences Inc.

31.15. RayBiotech Inc.

32. Global Prostate Specific Antigen (PSA) Test Market Competitive Benchmarking

33. Global Prostate Specific Antigen (PSA) Test Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Prostate Specific Antigen (PSA) Test Market

35. Prostate Specific Antigen (PSA) Test Market Future Outlook and Potential Analysis

35.1 Prostate Specific Antigen (PSA) Test Market In 2028 - Countries Offering Most New Opportunities

35.2 Prostate Specific Antigen (PSA) Test Market In 2028 - Segments Offering Most New Opportunities

35.3 Prostate Specific Antigen (PSA) Test Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Prostate Specific Antigen (PSA) Test Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Prostate Specific Antigen (PSA) Test Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Siemens AG Financial Performance

Table 75: F. Hoffmann-La Roche AG Financial Performance

Table 76: Bayer AG Financial Performance

Table 77: Abbott Laboratories Financial Performance

Table 78: Becton Dickinson and Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Prostate Specific Antigen (PSA) Test Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Prostate Specific Antigen (PSA) Test Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Prostate Specific Antigen (PSA) Test Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Prostate Specific Antigen (PSA) Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Prostate Specific Antigen (PSA) Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Siemens AG Financial Performance

Figure 75: F. Hoffmann-La Roche AG Financial Performance

Figure 76: Bayer AG Financial Performance

Figure 77: Abbott Laboratories Financial Performance

Figure 78: Becton Dickinson and Company Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Prostate Cancer Diagnostics Global Market Report 2024 – By Products (Instruments, Reagents And Consumables, Accessories), By Test Type (Preliminary Tests, Confirmatory Tests), By Prostate Cancer (Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma), By Peer Groups (Adult, Pediatric, Geriatrics), By End User (Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Test And Measurement Equipment Global Market Report 2024 – By Product (General Purpose Test Equipment (GPTE), Mechanical Test Equipment (MTE)), By Service Type (Calibration Services, Repair Services Or After-Sales Services), By Vertical (Automotive And Transportation, Aerospace And Defense, Information Technology (IT) And Telecommunication, Education And Government, Industrial, Healthcare, Semiconductor And Electronics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Testosterone Replacement Therapy Global Market Report 2024 – By Product Type (Oral, Implants, Gel Or Creams, Patches, Buccal Adhesive, Parenteral, Other Products), By Indication (Hypogonadism, Autoimmune Conditions, Genetic Disorders, Sex Organ Surgeries, Other Indications), By Active Ingredient Type (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate), By End User (Hospitals, Clinics, Other End-User) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Testing, Inspection, And Certification Global Market Report 2024 – By Service Type (Testing Service, Inspection Service, Certification Service), By Sourcing Type (In-House, Outsourced), By Application (Quality And Safety, Production Evaluation, Industrial Inspection, System Certification), By End-User (Consumer Goods And Retail, Food And Agriculture, Oil And Gas, Construction And Engineering, Energy And Chemicals, Manufacturing, Transportation, Industrial And Automotive, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Prostate Cancer Drugs Global Market Report 2024 – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2024 – By Target Antigen (CD19, CD22, Other Antigens), By Application (Acute Lymphoblastic Leukaemia, Diffuse Large B-Cell Lymphoma, Other Applications), By End User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Neoantigen Targeted Therapies Global Market Report 2024 – By Type (Monotherapy, Combination Therapy), By Immunotherapy Type (DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies), By Target Disease Indication (Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer), By Route of Administration (Intradermal, Intravenous, Subcutaneous), By Application (Medical Research Institution, Hospital, and Clinic, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Testing Software Global Market Report 2024 – By Type (System Integrator, Pureplay Testing Software), By Component (Application Testing, Services), By End-User (BFSI (Banking, Financial Service and Insurance), IT (Information Technology) And Telecom, Life Sciences And Healthcare, Media And Entertainment, Manufacturing, Energy And Utilities, Retail, Consumer Goods, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the prostate specific antigen (PSA) test market?

How will the prostate specific antigen (PSA) test market drivers and restraints affect the prostate specific antigen (PSA) test market dynamics? What forces will shape the prostate specific antigen (PSA) test industry going forward?

The prostate specific antigen (PSA) test market major growth driver - Increasing Prevalence Of Prostate Cancer Drives Growth In Prostate-Specific Antigen (PSA) Test Market. For further insights on the prostate specific antigen (PSA) test market, request a sample here

What is the forecast market size or the forecast market value of the prostate specific antigen (PSA) test market?

The prostate specific antigen (PSA) test market size has grown rapidly in recent years. It will grow from $3.66 billion in 2023 to $4.13 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to increased awareness, aging population, medical advancements, clinical recommendations, pharmaceutical advancements. The prostate specific antigen (PSA) test market size is expected to see rapid growth in the next few years. It will grow to $6.4 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to advancements in test accuracy, personalized medicine approach, personalized medicine approach, global aging population. Major trends in the forecast period include shift towards biomarker combinations, technological innovations, point-of-care testing, digital health integration, focus on early detection and prevention. For further insights on the prostate specific antigen (PSA) test market, request a sample here

How is the prostate specific antigen (PSA) test market segmented?

The prostate specific antigen (PSA) test market is segmented
1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types
2) By Application: Screening, Post-Treatment Monitoring, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End UsersFor further insights on the prostate specific antigen (PSA) test market, request a sample here

Which region has the largest share of the prostate specific antigen (PSA) test market? What are the other regions covered in the report?

North America was the largest region in the prostate specific antigen (PSA) test market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the prostate specific antigen (PSA) test market, request a sample here.

Who are the major players in the prostate specific antigen (PSA) test market?

Major companies operating in the prostate specific antigen (PSA) test market report are Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc., AOBIOUS Inc., Boster Biological Technology Co. Ltd., Cell Biolabs Inc., Lomina AG For further insights on the prostate specific antigen (PSA) test market, request a sample here.

What are the key trends in the prostate specific antigen (PSA) test market?

Major trend in the prostate specific antigen (PSA) test market - Technological Advancements Propel Innovation In The Prostate-Specific Antigen (PSA) Test Market. For further insights on the prostate specific antigen (PSA) test market, request a sample here.

What are the major opportunities in the prostate specific antigen (PSA) test market? What are the strategies for the prostate specific antigen (PSA) test market?

For detailed insights on the major opportunities and strategies in the prostate specific antigen (PSA) test market, request a sample here.

How does the prostate specific antigen (PSA) test market relate to the overall economy and other similar markets?

For detailed insights on prostate specific antigen (PSA) test market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the prostate specific antigen (PSA) test industry?

For detailed insights on the mergers and acquisitions in the prostate specific antigen (PSA) test industry, request a sample here.

What are the key dynamics influencing the prostate specific antigen (PSA) test market growth? SWOT analysis of the prostate specific antigen (PSA) test market.

For detailed insights on the key dynamics influencing the prostate specific antigen (PSA) test market growth and SWOT analysis of the prostate specific antigen (PSA) test industry, request a sample here.